Nanoparticles as an effective drug delivery system in COVID-19

被引:21
作者
Chowdhury, Neehasri Kumar [1 ]
Deepika [2 ]
Choudhury, Reshma [3 ]
Sonawane, Gaurav Ambadas [4 ]
Mavinamar, Shankar [5 ]
Lyu, Xiaoming [6 ]
Pandey, Ramendra Pati [7 ]
Chang, Chung-Ming [8 ]
机构
[1] Gauhati Univ, Dept Zool, Gauhati, Assam, India
[2] Deenbandhu Choturam Univ, Dept Biotechnol & Technol, Sonepat, Haryana, India
[3] Royal Global Univ, Dept Biotechnol, Gauhati, Assam, India
[4] Dept Pharm, Sanjivani Coll Pharmaceut Educ & Res, Kopargaon, India
[5] Karnataka State Akkamahadevi Womens Univ, Dept Bot, Vijayapura, India
[6] Southern Med Univ, Affiliated Hosp 3, Lab Med, 183 West Zhongshan Ave, Guangzhou, Peoples R China
[7] SRM Univ, Dept Biotechnol, Delhi NCR, Sonepat, India
[8] Chang Gung Univ, Master &Ph D Program Biotechnol Ind, 259 Wenhua Ist Rd, Taoyuan 33302, Taiwan
关键词
Covid-19; Nanoparticles; Drug delivery system; Bibliographic search; Treatment; BIODEGRADABLE NANOPARTICLES; CHITOSAN NANOPARTICLES; ALBUMIN NANOPARTICLES; CORONAVIRUS; GS-5734; REMDESIVIR; INFECTION; DIAGNOSIS; EFFICACY; RELEASE;
D O I
10.1016/j.biopha.2021.112162
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: The global healthcare sector has been dealing with a situation known as a novel severe acute res-piratory syndrome (SARS-CoV-2) since the end of 2019. Covid-19 is an acronym for Covid-19 (Coronavirus Disease-2019). It causes a respiratory infection that includes cold, sneezing and coughing, and pneumonia. In the case of an animal, it causes diarrhea and upper respiratory diseases. Covid-19 transmitted human to human via airborne droplets. First Covid-19 emerged in Wuhan market China and it spread rapidly throughout the World. As we know nanoparticles are a novel drug delivery system. They have various advantageous effects like increasing the efficacy of the drug, safety, etc. In this review, we study about the nanoparticles and summarize how it is effective during drug delivery system in Covid-19. Chitosan is a much focused biopolymeric nano-particle. It delivers drugs to the specific target site. In a recent health crisis, chitosan nanoparticles are one of the ways to release drugs of Covid-19, and specifically in the lungs of the affected patients. We studied and extracted our data from various research papers, review papers, and some other articles. Objective: The main goal is to study the nanoparticles and their future aspects which is an effective drug delivery system in Covid-19. Methods: The bibliographic search was done through a systematic search. The terms "Nanoparticles", "Covid-19 ", "Drug delivery" etc. were used to search the databases/search engines like "Google Scholar", "NCBI", "PubMed", "Science Direct" etc. These databases and search engines used here perform the limited criteria of search to conduct a systematic literature survey for the study and report writing. All the text from the articles and research papers were studied and analyzed. The various articles and research papers were used in writing this report and all of which are mentioned in the reference section of this report. Conclusion: Our current studies reveal that nanoparticles may prove very helpful in the delivery of drugs for Covid-19 treatment. Many cases showed that patients, where drugs are delivered with the help of nanoparticles, produced very few side effects.
引用
收藏
页数:10
相关论文
共 73 条
[1]   Diagnosis and treatment of coronavirus disease 2019 (COVID-19): Laboratory, PCR, and chest CT imaging findings [J].
Abbasi-Oshaghi, Ebrahim ;
Mirzaei, Fatemeh ;
Farahani, Farhad ;
Khodadadi, Iraj ;
Tayebinia, Heidar .
INTERNATIONAL JOURNAL OF SURGERY, 2020, 79 :143-153
[2]   Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease [J].
Agostini, Maria L. ;
Andres, Erica L. ;
Sims, Amy C. ;
Graham, Rachel L. ;
Sheahan, Timothy P. ;
Lu, Xiaotao ;
Smith, Everett Clinton ;
Case, James Brett ;
Feng, Joy Y. ;
Jordan, Robert ;
Ray, Adrian S. ;
Cihlar, Tomas ;
Siegel, Dustin ;
Mackman, Richard L. ;
Clarke, Michael O. ;
Baric, Ralph S. ;
Denison, Mark R. .
MBIO, 2018, 9 (02)
[3]  
Ali M., ROLE NANOTECHNOLOGY
[4]  
Bablani P., 2020, IJRAR INT J RES ANAL, V7
[5]   Nanoparticle Formulations in Pulmonary Drug Delivery [J].
Bailey, Mark M. ;
Berkland, Cory J. .
MEDICINAL RESEARCH REVIEWS, 2009, 29 (01) :196-212
[6]   Drug delivery and cytocompatibility of ciprofloxacin loaded gelatin nanofibers-coated Mg alloy [J].
Bakhsheshi-Rad, H. R. ;
Hadisi, Z. ;
Hamzah, E. ;
Ismail, A. F. ;
Aziz, M. ;
Kashefian, M. .
MATERIALS LETTERS, 2017, 207 :179-182
[7]   Hydroxychloroquine: From Malaria to Autoimmunity [J].
Ben-Zvi, Ilan ;
Kivity, Shaye ;
Langevitz, Pnina ;
Shoenfeld, Yehuda .
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2012, 42 (02) :145-153
[8]   Influence of crosslinked alginate on drug release from highly concentrated emulsions [J].
Bonilla, Pablo ;
Arias, Eva M. ;
Solans, Conxita ;
Jose Garcia-Celma, Maria .
COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 2018, 536 :148-155
[9]   Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase [J].
Brown, Ariane J. ;
Won, John J. ;
Graham, Rachel L. ;
Dinnon, Kenneth H., III ;
Sims, Amy C. ;
Feng, Joy Y. ;
Cihlar, Tomas ;
Denison, Mark R. ;
Baric, Ralph S. ;
Sheahan, Timothy P. .
ANTIVIRAL RESEARCH, 2019, 169
[10]   Microemulsion utility in pharmaceuticals: Implications for multi-drug delivery [J].
Callender, Shannon P. ;
Mathews, Jessica A. ;
Kobernyk, Katherine ;
Wettig, Shawn D. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 526 (1-2) :425-442